Vote for Resistell at
Top100 Startup
competition.
VOTE NOW!
Resistell News:

Resistell AG receives €2.5M EIC Accelerator grant and equity financing offer from EIC

newsimage
newsimage
Resistell News:

Resistell AG receives €2.5M EIC Accelerator grant and equity financing offer from EIC

Resistell AG, the start-up developing world’s fastest phenotypic antibiotic susceptibility test was selected for funding under the European Innovation Council (EIC) programme in the latest funding round. Resistell’s project RAPID-SEP-AST will receive up to €2.5M grant and additional equity financing from EIC Fund.
curves

Latest news

25th June 2018

Scientists Are Using a New Weapon to Fight Drug-Resistant Bacteria—Viruses

New treatments like phage therapy are being used to fight the deadly risk of antibiotic resistance, and Resistell is working to speed up and improve the identification of bacteria and the prescription of the correct medicines.
news image news image
11th June 2018

The Best Swiss Nanotechnology Startup 2018

We are please to share that on 07.06.2018 in Zurich, Resistell has received the Swiss Nanotechnology Startup Award for the Best Nanotechnology Startup 2018.
news image news image
6th June 2018

Resistell qualifies as a finalist of MassChallenge Switzerland 2018

Last week, we competed with over 200 startups from 31 countries in final judging round at Campus Biotech in Geneva. We are pleased to inform that Resistell AG qualified to the finals!
news image news image
4th June 2018

31.05.2018 - Resistell the winner of Venture Kick stage 2

31.05.2018 - Resistell's team has won the Venture Kick stage 2!
1st June 2018

Antibiotic resistance crisis worsening because of collapse in supply

The Access To Medicine foundation warns that antibiotic supply chain issues are helping to fuel the rise in AMR Their solution? ‘The right products need to reach the right patients at the right time’ - exactly what Resistell is working toward.
24th May 2018

The Antibiotics Problem

Discover how the search for a rapid diagnostic system lies at the heart of tackling antibiotic resistance, a problem which is predicted to kill 10 million people a year by 2050. Resistell is working to create the innovative solutions needed.
news image news image
20th April 2018

Containing Unusual Resistance

The Centers for Disease Control and Prevention (CDC) have outlined the ways in which health departments can prevent the spread of antibiotic resistance. Rapid identification of resistant bacteria is at the heart of their strategy. Resistell is helping to make that a reality.